✦ LIBER ✦

Thymic lymphocytes in myasthenia gravis

✍ Scribed by Dr. Gary Birnbaum; Peter Tsairis

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 239 KB
Volume: 1
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410010404

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Lymphocytes from the thymus glands of myasthenic patients and controls were characterized in terms of their percentages of B‐ and T‐cells and their ability to stimulate the proliferation of autologous peripheral blood lymphocytes. Percentages of B‐ and T‐cells were the same in the thymuses of myasthenic and control subjects. Autologous peripheral lymphocyte stimulation by thymocytes was observed in only 1 of 3 myasthenic patients, and this was with a thymus gland containing a thymoma. These results thus differ from those of other investigators.

📜 SIMILAR VOLUMES

Plasmapheresis in myasthenia gravis

✍ Robert G. Miller 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Diagnostic difficulties in myasthenia gr

Diagnostic difficulties in myasthenia gravis

✍ John Maher; François Grand'maison; Michael W. Nicolle; Michael J. Strong; Charle 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

Four patients with myasthenia gravis presented with severe, largely isolated, bulbar and respiratory muscles weakness. Tensilon tests were positive and antiacetylcholine receptor (anti-AChR) antibody titers were negative in all patients. Only 1 patient had a greater than 10% decremental response dur

Pupillary dysfunction in myasthenia grav

Pupillary dysfunction in myasthenia gravis

✍ Frederick E. Lepore; George E. Sanborn; Dr John T. Slevin 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

## Abstract The constriction‐dilation cycles of pupils exposed to a stationary, discrete slit‐lamp beam were significantly prolonged in 25 myasthenic patients (1,060.4 ± 45.8 msec) undergoing therapy with steroids, anticholinesterases, or both, compared to normal controls (801.9 ± 8.6 msec) or subj

Immunoglobulin treatment in refractory m

Immunoglobulin treatment in refractory myasthenia gravis

✍ Anat Achiron; Yoram Barak; Shmuel Miron; Ida Sarova-Pinhas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

Failure to induce and maintain remission in severe exacerbations of myasthenia gravis (MG), despite optimal care, is a common problem. We evaluated the efficacy and safety of high-dose intravenous immunoglobulin (IVIg) therapy in an open-label study of 10 patients with severe generalized myasthenia

Myasthenia gravis in the tenth decade

✍ Lawrence H. Phillips II; Vern C. Juel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

Targeting T cells in myasthenia gravis

✍ Daniel B. Drachman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views